This modality uses tDCS to modulate cortical excitability and promote neuroplasticity alongside cognitive training to enhance brain function and facilitate recovery (Uehara et al., 2025)
Albiglutide was approved for once-weekly treatment of T2DM, and marketed as Tanzeum/Eperzan from 2014 to 2018 by GlaxoSmithKline 32 , before the company discontinued the product due to financial priorities in a highly competitive market
ClarkeSFMurphyEFOSullivanOLuceyAJHumphreysMHoganAet al
This triggers a faster, more powerful pulse of growth hormone release
Protective role of PGC-1alpha in diabetic nephropathy is associated with the inhibition of ROS through mitochondrial dynamic remodeling
MIC is a fat burning compound that combines three amino acids, methionine, inositol, and choline